NCT06581718

Brief Summary

Robotic controlled endoscopy of GI tract.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

August 30, 2024

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 3, 2024

Completed
Last Updated

September 3, 2024

Status Verified

August 1, 2024

Enrollment Period

3 months

First QC Date

August 30, 2024

Last Update Submit

August 30, 2024

Conditions

Cancer Gi

Outcome Measures

Primary Outcomes (3)

  • Time of completion

    6 months

  • User Experience survey

    6 months

  • Patient Experience survey

    6 months

Study Arms (1)

Eye Gaze

EXPERIMENTAL
Device: Eye Gaze Control

Interventions

Eye Gaze ControlDEVICE

Eye Gaze Control - UGI and LGI endoscopy

Eye Gaze

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Routine UGI endoscopic indications

You may not qualify if:

  • Varices
  • \<18
  • GI haemorrhage
  • PS \> 2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imperial College London

London, Lonodon, W21NY, United Kingdom

RECRUITING

MeSH Terms

Conditions

Gastrointestinal Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2024

First Posted

September 3, 2024

Study Start

May 1, 2024

Primary Completion

August 1, 2024

Study Completion

September 1, 2024

Last Updated

September 3, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations

GB(1)